Zoetis Inc. (NYSE:ZTS) Shares Sold by Quotient Wealth Partners LLC

Quotient Wealth Partners LLC lowered its stake in Zoetis Inc. (NYSE:ZTS) by 13.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,095 shares of the company’s stock after selling 467 shares during the period. Quotient Wealth Partners LLC’s holdings in Zoetis were worth $504,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. AMF Tjanstepension AB grew its holdings in Zoetis by 23.4% during the third quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock worth $20,594,000 after acquiring an additional 20,001 shares during the period. CWM LLC lifted its position in shares of Zoetis by 1.8% in the third quarter. CWM LLC now owns 19,330 shares of the company’s stock valued at $3,777,000 after acquiring an additional 339 shares in the last quarter. LVW Advisors LLC increased its position in Zoetis by 11.8% during the 3rd quarter. LVW Advisors LLC now owns 1,470 shares of the company’s stock worth $287,000 after purchasing an additional 155 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Zoetis by 307.5% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,930 shares of the company’s stock valued at $572,000 after purchasing an additional 2,211 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its holdings in Zoetis by 1.1% in the 3rd quarter. Valeo Financial Advisors LLC now owns 8,028 shares of the company’s stock valued at $1,568,000 after purchasing an additional 91 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Zoetis Trading Down 1.6 %

NYSE ZTS opened at $171.37 on Monday. The company’s fifty day simple moving average is $169.26 and its 200-day simple moving average is $179.22. The stock has a market cap of $77.32 billion, a P/E ratio of 32.21, a PEG ratio of 2.77 and a beta of 0.90. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be given a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. Zoetis’s payout ratio is currently 37.59%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ZTS. Morgan Stanley reduced their price objective on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 29th. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. UBS Group initiated coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus dropped their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Finally, Leerink Partners began coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target on the stock. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $215.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.